Longitudinal profiling of serum ADAM17 across clinical stages in multiple myeloma: a dynamic biomarker and its association with T cell alterations.

Front Mol Biosci · 2026 · PMC12900718 · PMID 41696582

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, the differences did not reach statistical significance, a finding that is likely attributable to the limited sample size. 3.3 Higher serum ADAM17 levels indicated poor renal function in MM patients To further investigate the potential of serum ADAM17 in characterizing disease status in MM patients, we demonstrated its precise reflection of renal functi

also in 111,027 other papers

an increasing trendno p-value reported

Specifically, ADAM17 concentrations demonstrated an increasing trend corresponding with advancing disease stage.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.